How Should Aesthetic Clinicians Select Energy-Based Devices For Striae Rubra Vs Striae Alba? A Stage-Based Approach To Treatment.

Match the device to the biology of the striae, not simply to their appearance. Striae rubra are vascular, erythematous, and more biologically active, so vascular-targeted lasers and conservative fractional remodeling are usually the logical starting points. Striae alba are mature, hypopigmented, and atrophic; they generally require collagen-remodeling technologies such as fractional lasers or microneedle radiofrequency, with expectations focused on improvement rather than eradication.

The treatment objective changes with maturation: reduce vascular redness in striae rubra, while improving dermal atrophy and texture in striae alba. Multiple treatments are usually required, and the final result should be judged months after the treatment series—not immediately after the last session.

Start With a Clinical Assessment

Confirm the Striae Stage

Striae rubra typically appear pink, red, or violaceous and may be relatively recent. Their increased microvascularity makes hemoglobin a relevant treatment target.

Striae alba are mature white or hypopigmented lesions with epidermal flattening, collagen loss, fine wrinkling, and variable depression. Their dominant problem is structural rather than vascular.

The transition between stages is gradual, so mixed presentations are common. A single patient may require different treatment priorities in different anatomical areas.

Assess Factors That Change Device Selection

Before selecting a device, assess:

Skin phototype and tanning status
Degree of erythema or hypopigmentation
Width, depth, and number of striae
Anatomic location and skin thickness
History of post-inflammatory hyperpigmentation or abnormal scarring
Pregnancy, breastfeeding, medications, and conditions affecting wound healing
Acceptable downtime and tolerance for adverse effects

This assessment is essential because the same fluence, density, or pulse duration can be appropriate for one patient and excessive for another.

Treat Striae Rubra as a Vascular and Remodeling Problem

Choose Vascular-Targeted Technology for Redness

Pulsed dye lasers and other vascular systems in the approximately 585–595 nm range can target hemoglobin within the dilated superficial vessels associated with erythematous striae.

Long-pulsed Nd:YAG systems may also be considered in appropriate cases, particularly when the clinician wants a different balance of penetration and vascular targeting. Device choice should follow the lesion’s depth, vascularity, skin phototype, and the operator’s experience.

Consider Fractional Remodeling When Texture Also Matters

Non-ablative fractional lasers can address early dermal remodeling while producing less surface disruption than ablative resurfacing.

They are particularly reasonable when striae rubra have both visible redness and early textural change. However, fractional treatment should not be presented as a substitute for vascular treatment when erythema is the primary concern.

Use Conservative Parameters and Test Responsiveness

Energy settings should be selected according to the specific device, wavelength, pulse structure, spot size, skin type, and treatment endpoint. There is no universally safe setting that can be transferred between platforms.

Darker skin types and recently tanned skin require particular caution because vascular or fractional energy can trigger post-inflammatory hyperpigmentation. Test spots, conservative initial settings, strict photoprotection, and staged escalation are prudent safeguards.

Treat Striae Alba as a Structural Remodeling Problem

Use Fractional Lasers to Induce Neocollagenesis

Non-ablative fractional Er:Glass systems, commonly operating around 1,540–1,550 nm, create controlled dermal thermal injury while preserving much of the epidermis.

Ablative fractional CO₂ or Er:YAG lasers create more pronounced microthermal or microablative zones. They may offer stronger resurfacing and remodeling, but they also involve greater downtime and a higher risk of pigmentary complications.

Consider Microneedle Radiofrequency for Dermal Atrophy

Microneedle RF delivers mechanical penetration and radiofrequency heating into the dermis. This can be useful when the main goals are improving depression, laxity, and irregular texture rather than removing color.

Its suitability depends on needle depth, energy delivery, skin type, anatomical site, and the clinician’s ability to control thermal exposure. It should be selected as a remodeling tool, not as a guaranteed method of restoring normal skin structure.

Treat Picosecond Devices as a Selective Option

Picosecond devices may be used for textural remodeling through photomechanical or fractional approaches, depending on the handpiece and platform.

Their role should be judged by the specific technology and available clinical evidence rather than by the word “picosecond” alone. Device category does not eliminate the need for appropriate parameters, patient selection, and outcome tracking.

Set Parameters Around Safety and Endpoints

Do Not Copy Settings Between Devices

Fluence, pulse duration, density, coverage, penetration depth, and pulse stacking are not interchangeable across manufacturers or wavelengths.

A suggested percentage reduction from acne-scar settings may be a useful starting concept, but it is not a validated universal prescription for striae. The clinician should instead begin conservatively, evaluate the immediate endpoint, and adjust over subsequent sessions.

Balance Density Against Healing Capacity

Higher density can increase the amount of remodeling but also increases inflammation, downtime, and pigmentary risk.

Because striae are relatively thin dermal scars, aggressive treatment is not automatically better. The objective is controlled remodeling with predictable healing, not maximal visible injury.

Use Phototype-Specific Risk Control

Patients with darker skin types have a greater risk of post-inflammatory hyperpigmentation after vascular, fractional, or ablative procedures.

Risk reduction includes conservative settings, careful treatment spacing, avoidance of active tanning, rigorous photoprotection, and appropriate management of inflammation. The clinician should also explain that hypopigmented striae alba may remain visibly different even when texture improves.

Build Expectations Around Gradual, Partial Improvement

Explain What Treatment Can and Cannot Do

Energy-based treatment can improve redness, contrast, texture, pliability, and apparent depth. It generally cannot recreate completely normal skin or guarantee removal of every visible line.

Complete eradication is uncommon. A realistic goal is measurable blending and softening of the striae, with the degree of improvement varying by age, depth, location, skin type, and treatment response.

Plan a Series Rather Than a Single Session

Most patients require multiple sessions spaced several weeks apart. The appropriate interval depends on the modality, treatment intensity, healing response, and whether the procedure is non-ablative, ablative, or needle-based.

The number of treatments should be reassessed after each session rather than promised in advance. Photographic documentation under consistent lighting is more reliable than memory when judging gradual change.

Delay Final Assessment

Collagen remodeling continues after treatment, so early post-procedure appearance does not represent the final result.

Texture and depth should generally be reassessed several months after the treatment course, with three to six months being a practical window for evaluating maturation of neocollagenesis.

Understanding the Trade-offs

Vascular Lasers Improve Color More Than Atrophy

Vascular devices are best aligned with the redness of striae rubra. They are less likely to correct the deeper depression and collagen loss of mature striae alba on their own.

Patients should therefore understand that fading erythema does not necessarily mean that the striae will become level with surrounding skin.

Ablative Fractional Devices Offer More Remodeling but More Risk

Fractional CO₂ and Er:YAG treatments can provide stronger resurfacing and collagen stimulation than many non-ablative approaches.

The trade-offs include more downtime, discomfort, post-treatment inflammation, and greater risk of pigmentary alteration or other complications. They are not automatically the best choice for every patient or every body site.

Non-Ablative and RF Approaches Are More Tolerable but May Be Subtler

Non-ablative fractional lasers and microneedle RF generally offer a more favorable downtime profile.

Their improvement may be slower or less dramatic, particularly in broad, deeply atrophic striae. A lower-downtime treatment is valuable only if its expected improvement matches the patient’s priorities.

Avoid Trend-Driven Device Purchasing

A practice should select technology based on demonstrated clinical reliability, appropriate indications, safety controls, service support, and the ability to treat its actual patient population.

Frequent equipment changes driven by industry trends can undermine consistency. Outcomes, patient satisfaction, documentation quality, and staff competence are more meaningful measures than novelty alone.

How to Apply This to Your Project

Use a staged consultation and treatment plan rather than offering one universal “stretch-mark laser.”

If your primary focus is early striae rubra: Prioritize vascular-targeted treatment for erythema, consider adjunctive non-ablative fractional remodeling when texture is also involved, and use conservative settings with particular attention to pigmentary risk.
If your primary focus is mature striae alba: Prioritize dermal remodeling with non-ablative or ablative fractional lasers, microneedle RF, or a carefully selected picosecond approach, while explaining that improvement will be partial and gradual.
If your primary focus is darker skin or high pigmentary risk: Favor conservative, staged treatment and robust photoprotection, with test spots and careful follow-up before increasing intensity.
If your primary focus is practice reliability: Choose platforms with appropriate indications, reproducible controls, clinical support, and documented outcomes rather than selecting equipment primarily because it is new.

The most credible treatment plan matches the device to the striae’s stage, controls risk, and defines success as meaningful improvement—not impossible perfection.

Summary Table:

Stage	Primary Target	Recommended Devices	Treatment Goal	Expectations
Striae Rubra (early)	Vascular erythema	PDL (585-595 nm), long-pulsed Nd:YAG; non-ablative fractional for texture	Reduce redness, early remodeling	Fade erythema; possible textural improvement
Striae Alba (mature)	Dermal atrophy	Non-ablative fractional (Er:Glass), ablative fractional (CO₂, Er:YAG), microneedle RF, picosecond	Improve texture, pliability, apparent depth	Partial, gradual improvement; not complete eradication
Darker skin/high pigment risk	Both stages with caution	Conservative settings on any device; test spots; strict photoprotection	Prevent PIH while treating	Lower treatment intensity; slower progress
Mixed presentations	Tailor per area	Combination of vascular and remodel devices	Address redness and atrophy	Realistic about area-specific outcomes

Consult our specialists at BELIS to find the right device for your practice. We offer a full range of medical aesthetic equipment, from vascular and fractional lasers to microneedle RF and picosecond systems, backed by clinical support and training. Whether you're targeting striae rubra or alba, we'll help you match technology to biology for better outcomes. Contact us today to schedule a consultation and elevate your treatment offerings.